benefits of using cd38 inhibitor with 5-amino-1mq Nicotinamide N-Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets Frontiers | Nicotinamide N-methyltransferase (NNMT):
Frontiers Nicotinamide N methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome Discovery of a First in Class CD38 Inhibitor for the Treatment of Mitochondrial Myopathy Journal of Medicinal Chemistry A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline ScienceDirect US20200102274A1 Quinoline derived small molecule inhibitors of nicotinamide n methyltransferase (nnmt) and uses thereof Google Patents
Pay in 4 interest-free payments of $7.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13


